Social functioning and quality of life in schizophrenia patients - Relationship with symptomatic remission and duration of illness;Funkcjonowanie społeczne i jakość życia u chorych na schizofrenię – zależność z remisją objawową i czasem trwania choroby

Psychiatria Polska

Volumn 48, Issue 2, 2014, Pages 277-288

  Goŕna, Krystyna ^a   Jaracz, Krystyna ^a   Jaracz, Jan ^b   Kiejda, Justyna ^a   Grabowska Fudala, Barbara ^a   Rybakowski, Janusz ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Klinika Psychiatrii Dorosłych   (Poland)

Author keywords

Quality of life; Remission; Schizophrenia; Social functioning

Indexed keywords

ARTICLE; DISEASE DURATION; GLOBAL ASSESSMENT SCALE; HUMAN; MAJOR CLINICAL STUDY; POSITIVE AND NEGATIVE SYNDROME SCALE; QUALITY OF LIFE; RATING SCALE; REMISSION; SCHIZOPHRENIA; SOCIAL FUNCTIONING SCALE; SOCIAL INTERACTION; WHO QUALITY OF LIFE SCALE; ADULT; ANTISOCIAL PERSONALITY DISORDER; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HOSPITALIZATION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; SOCIAL ADAPTATION; SOCIAL SUPPORT; STATISTICS; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT; SOCIAL BEHAVIOR DISORDERS; SOCIAL SUPPORT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84899549163     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bellack AS. Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications. Schizophr. Bull. 2006; 32(3): 432-442. (Pubitemid 43992317)
2. Tandon R, Nasrallah HA, Keshavan MS. Schizophrenia, "just the facts" 5. Treatment and prevention past, present, and future. Schizophr. Res. 2010; 122(1): 1-23.
3. Bobes J, Álvarez E, San L, Novick D, Gilaberte I. Clinical meaningful outcomes in schizophrenia: remission and recovery. Rev. Psiquiatr. Salud Ment. 2011; 4(1): 53-65.
4. Remington G, Foussias G, Agid O. Progress in defining optimal treatment outcome in schizophrenia. CNS Drugs 2010; 24(1): 9-20.
5. Wciórka J. Psychozy schizofreniczne, zaburzenia schizotypowe i schizoafektywne. W: Pużyński S, Wciórka J, Rybakowski R. red. Psychiatria. Psychiatria kliniczna. Tom II, wyd. 2. Wrocław: Elsevier Urban & Partner; 2011. s. 195-265.
6. Davidson L, Roe D, Andres-Hyman R, Ridgway P. Applying stages of change models to recovery from serious mental illness: contributions and limitations. Isr. J. Psychiatry 2010; 47(3): 213-221.
7. Liberman RP, Kopelowicz A. Recovery from schizophrenia: a challenge for the 21st century. Int. Rev. Psychiatry 2002; 14(4): 245-255. (Pubitemid 35398851)
8. Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am. J. Psychiatry 2005; 162(3): 441-449. (Pubitemid 40343909)
9. Cechnicki A. Schizofrenia - proces wielowymiarowy. Krakowskie prospektywne badania przebiegu, prognozy i wyników leczenia schizofrenii. Instytut Psychiatrii i Neurologii: Warszawa; 2011.
10. Jääskeläinen E. Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M i wsp. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr. Bull. 2012; 39(6): 1296-1306.
11. AlAqeel B, Margolese HCR. Remission in schizophrenia: critical and systematic review. Harv. Rev. Psychiatry 2013; 20(6): 281-297.
12. Eack SM, Newhill CE. Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis . Schizophr. Bull. 2007; 33(5): 1225-1237. (Pubitemid 47347913)
13. Wolter A, Preuss U, Krischke N, Wong JW, Langosch JM, Zimmermann J. Recovery und remission bei schizophrenie. Fortschr. Neurol. Psychiatr. 2010; 78(8): 468-474.
14. Thorup A, Petersen L, Jeppesen P, Nordentof M. The quality of life among first-episode psychotic patients in the Opus trial. Schizophr. Res. 2010; 116(1): 27-34.
15. Cechnicki A, Valdes M. Relation between schizophrenic patients' quality of life and symptom severity. Arch. Psychiatr. Psychother. 2003; 5(3): 55-68.
16. Galuppi A, Turola MC, Nanni MG, Mazzoni P, Grassi L. Schizophrenia and quality of life: how important are symptoms and functioning. Int. J. Ment. Health Syst. 2010; 4(1): 1-8.
17. Rocca P, Giugiario M, Montemagni C, Rigazzi C, Rocca, G, Bogetto F. Quality of life and psychopathology during the course of schizophrenia. Compr. Psychiatry 2009; 50(6): 542-548
18. Rocca P, Pulvirenti L, Montemagni C, Rasetti R, Rocca G, Bogetto F. Basic symptoms in stable schizophrenia: relations with functioning and quality of life. Clin. Neuropsychiatry 2010; 7(3): 100-110.
19. Hunter R, Barry S. Negative symptoms and psychosocial functioning in schizophrenia: neglected but important targets for treatment. Eur. Psychiatry 2012; 27(6): 432-436.
20. Lambert M, Karow A, Leucht S, Schimmelmann BG, Naber D. Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later . Dialogues Clin. Neurosci. 2010; 12(3): 393-407.
21. Brissos S, Molodynski A, Dias VV, Figueira ML. The importance of measuring psychosocial functioning in schizophrenia. Ann. Gen. Psychiatry 2011; 10(1): 18.
22. Jaracz K, Górna K, Kiejda J, Rybakowski J. Prospektywna ocena wczesnego przebiegu schizofrenii u kobiet i mȩżczyzn po pierwszej hospitalizacji psychiatrycznej. Psychiatr. Pol. 2008; 42(1): 33-46. (Pubitemid 351570684)
23. Górna K, Jaracz K, Rybakowski F, Rybakowski J. Determinants of objective and subjective quality of life in first-time-admission schizophrenic patients in Poland: a longitudinal study. Qual. Life Res. 2008; 7(2): 237-247.
24. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987; 13(2): 261-276. (Pubitemid 18039085)
25. Helldin L, Kane JM, Hjärthag F, Norlander T. The importance of cross-sectional remission in schizophrenia for long-term outcome: a clinical prospective study. Schizophr. Res. 2009; 115(1): 67-73.
26. Załuska M. Skala Funkcjonowania Społecznego (SFS) Birchwooda jako narzȩdzie oceny funkcjonowania chorych na schizofreniȩ. Post. Psychiatr. Neurol. 1997; 6: 237-251.
27. Jaracz K, Kalfoss M, Górna K, Ba̧czyk G. Quality of life in Polish respondents: psychometric properties of the Polish WHOQOL-Bref. Scand. J. Caring Sci. 2006; 20(3): 251-260. (Pubitemid 44266493)
28. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The Global Assessment Scale. Arch. Gen. Psychiatry 1976; 33(6): 766-771.
29. Sprangers MAG, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc. Sci. Med. 1999; 48(11): 1507-1515. (Pubitemid 29254110)
30. Franz M, Meyer T, Reber T, Gallhofer B. The importance of social comparisons for high levels of subjective quality of life in chronic schizophrenic patients. Qual. Life Res. 2000; 9(5): 481-489. (Pubitemid 32009858)
31. Jaracz K, Górna K. Ocena jakości życia w świetle nowych ustaleńteoretycznych i metodologicznych. Przew. Lek. 2005; 74(6): 740-745.
32. Brissos S, Dias VV, Balanzá-Martinez V, Carita AI, Figueira ML. Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance. Schizophr. Res. 2011; 129(2): 133-136.
33. Karow A, Moritz S, Lambert M, Schöttle D, Naber D. Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia. Eur. Psychiatry 2012; 27(6): 401-405.